Upcoming events
________________________________
Impulse meets EPOC
Get ready for an exciting journey – From inventor to innovator
16 Mill Lane Cambridge CB2 1SB
Tuesday, 25 February 2020 from 18:00 to 20:30 (GMT)
Are you ready for the next step to make your innovative idea/project a reality?
Impulse, the Cambridge entrepreneurship programme for tech innovators based at the Maxwell Centre, helps you to transform your innovative research idea/ project into a “high potential” business case. More than 80 top-tier entrepreneurs, innovators, investors and industry experts share their expertise, offer senior level mentoring and guidance. The programme provides a unique learning environment for participants helping them to transform scientific breakthroughs into market-ready solutions.
Accept the challenge and join our event to learn more about Impulse and sponsorship opportunities, get inspired by one of our mentors and listen how other Postdocs experienced the Impulse programme.
Agenda
6:00 – 6:15 Registration
6:15 – 6:30 Impulse – The Cambridge entrepreneurship programme for tech innovators
Yupar Myint, Head of Impulse
6:30 – 7:10 Accept the challenge – Become an innovator
Fiona Nielsen, Repositive
7:10 – 7:30 The innovator's journey - Insights and learnings from Impulse alumni
Chris Proctor, Cambridge Bioelectronics
Gita Khalili Moghaddam, GlycoVue
7:30 – 8:30 Networking session (nibbles and drinks)
Register: https://www.eventbrite.co.uk/e/get-ready-for-an-exciting-journey-from-in...
________________________________
From Research to science entrepreneur to Nobel Prize Winner: Greg Winter
Bristol-Myers Squibb Lecture Theatre, 29 Lensfield Road , Cambridge , CB2 1ER
Tue, 3 March 2020, 18:00 – 21:00
About the event :
We're delighted to host Greg Winter, Cambridge's very own Nobel Prize winning molecular biologist who will talk about his journey going from researcher to a world leading life sciences innovator and entrepreneur within the field of antibody therapeutics.
In recent years the application of genetic engineering technologies and/or laboratory-based evolution have led to the development of antibodies as a new class of pharmaceutical drugs. Many of the best-selling drugs are now antibodies, and continuing technology development is opening up new prospects for antibody therapeutics, and for other peptide- and protein-based drugs created in like manner.
Agenda:
6pm - 6.15pm - registration
6.15pm -7.30pm - talk
7.30pm - 9pm - food and networking
Register: https://www.eventbrite.co.uk/e/from-researcher-to-science-entrepreneur-t...